AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
Continued execution across Ampligen^® clinical development programs and growing body of positive data in multiple high-value..
Continued execution across Ampligen^® clinical development programs and growing body of positive data in multiple high-value..
PDUFA Target Action Date of June 26, 2024Eight posters including two oral presentations support potential of ensifentrine,
an..
*NORTHAMPTON, MA / ACCESSWIRE / April 9, 2024 /* DICK'S Sporting Goods
*Written by Hilary Totin*
Originally..